A 3D whole brain convolutional neural network could provide enhanced sensitivity and specificity for diagnosing intracranial hemorrhages on computed tomography, according to new research presented at the Society for Imaging Informatics in Medicine (SIIM) conference in Kissimmee, Fla.
Radiology researchers from Emory University suggested that the use of a 3D whole brain convolutional neural network (CNN) may not only improve the diagnosis of intracranial hemorrhages, but it could facilitate the classification of subarachnoid hemorrhages (SAHs) on non-contrast computed tomography (CT) as well.
In a new poster abstract presentation at the Society for Imaging Informatics in Medicine (SIIM) conference in Kissimmee, Fla., the study authors said their 3D whole brain CNN demonstrated an area under the curve (AUC) of 0.98, 93 percent sensitivity and 94 percent specificity in detecting intracranial hemorrhages.
Acknowledging previous research that demonstrated the relationship between SAH and aneurysmal rupture location, the study authors were intrigued by the potential ability of a CNN to diagnose intracranial hemorrhages and differentiate between aneurysmal and non-aneurysmal SAHs.
“ … The additional spatial context afforded by a 3D neural network architecture may enable downstream classification of aneurysmal subarachnoid hemorrhages (aSAHs) versus non-aneurysmal subarachnoid hemorrhages (naSAHs),” wrote Ranliang Hu, M.D., the director of stroke imaging and the associate program director of the neuroradiology fellowship in the Division of Neuroradiology at the Emory University School of Medicine, and colleagues.
Accordingly, the researchers trained their 3D whole brain CNN with a combination of an intracranial hemorrhage data set from the Radiological Society of North America (RSNA) and institutional data sets of catheter angiography proven aneurysmal subarachnoid hemorrhages (aSAH) and non-aneurysmal subarachnoid hemorrhages (naSAH).
After refining their CNN model to test for the detection of naSAH and aSAH, Hu and colleagues found an AUC of .95, 89 percent sensitivity and 86 percent specificity for diagnosing naSAH. The CNN model also had an AUC of .83, 77 percent sensitivity and 81 percent specificity for diagnosing aSAH, according to the poster abstract.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
GE HealthCare Launches PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.